Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023;55(3):240.
doi: 10.5114/ait.2023.130638.

Commentary on "An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant"

Affiliations
Comment

Commentary on "An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant"

Sumit Chowdhury et al. Anaesthesiol Intensive Ther. 2023.
No abstract available

PubMed Disclaimer

Conflict of interest statement

none.

Comment in

Comment on

References

    1. Paredes S, Torres V, Chaves-Cardona H, Matus M, Porter S, Renew J. An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant. Anaesthesiol Intensive Ther 2023; 55: 241-242. doi: 10.5114/ait.2023.130640. - DOI - PMC - PubMed
    1. Kheterpal S, Vaughn MT, Dubovoy TZ, et al. . Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology 2020; 132: 1371-1381. doi: 10.1097/ALN.0000000000003256. - DOI - PMC - PubMed
    1. Wu EB, Huang SC, Lu HI, et al. . Use of rocuronium and sugammadex during video-assisted thoracoscopic surgery is associated with reduced duration of chest-tube drainage: a propensity score-matched analysis. Br J Anaesth 2023; 130: e119-e127. doi: 10.1016/j.bja.2022.07.046. - DOI - PubMed
    1. Lenner R, Padilla ML, Teirstein AS, Gass A, Schi-lero GJ. Pulmonary complications in cardiac transplant recipients. Chest 2001; 120: 508-513. doi: 10.1378/chest.120.2.508. - DOI - PubMed
    1. Roest S, Hesselink DA, Klimczak-Tomaniak D, et al. . Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival. ESC Heart Failure 2020; 7: 533-541. doi: 10.1002/ehf2.12585. - DOI - PMC - PubMed